[1]
Aslonov I.F., «IMPACT OF COMORBID CONDITIONS ON THE DEVELOPMENT OF NEPHROTOXICITY IN PATIENTS RECEIVING ANTI-TUBERCULOSIS THERAPY», CAJM, т. 1, вып. 11, сс. 240–245, янв. 2026, просмотрено: ноя. 19, 2026. доступно на: https://journals.tnmu.uz/index.php/cajm/article/view/3413